Should Race-Genotype Interactions Be Considered in the Global Development of CYP2C19 Substrates? A Proposed Framework Using Physiologically Based Pharmacokinetic Modeling-Reference-Cited by-同舟云学术

Should Race-Genotype Interactions Be Considered in the Global Development of CYP2C19 Substrates? A Proposed Framework Using Physiologically Based Pharmacokinetic Modeling

Published:2016-12-22 Issue:4 Volume:57 Page:417-421
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Patel Chirag¹,Rathi Chetan²,Venkatakrishnan Karthik¹

Affiliation:

1. Takeda Pharmaceuticals International Company; Cambridge MA, USA

2. University of Tennessee Health Science Center; Memphis TN, USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference14 articles.

1. Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors;Ichimaru;Clin Pharmacol Ther.,2010

2. Toward optimum benefit-risk and reduced access lag for cancer drugs in Asia: a global development framework guided by clinical pharmacology principles;Venkatakrishnan;Clin Transl Sci.,2016

3. Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice;Huang;Clin Pharmacol Ther.,2008

4. Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development;Kurose;Drug Metab Pharmacokinet.,2012

5. Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans;Man;J Clin Pharmacol.,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene–Drug–Drug Interactions;CPT: Pharmacometrics & Systems Pharmacology;2019-07-03

2. Complex Drug–Drug–Gene–Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives;Clinical Pharmacokinetics;2018-04-17

3. Impact of CYP2D6 Functional Allelic Variations on Phenoconversion and Drug-Drug Interactions;Clinical Pharmacology & Therapeutics;2017-11-06